1. Home
  2. MTH vs RLAY Comparison

MTH vs RLAY Comparison

Compare MTH & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meritage Homes Corporation

MTH

Meritage Homes Corporation

N/A

Current Price

$71.68

Market Cap

4.9B

ML Signal

N/A

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$19.44

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTH
RLAY
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.1B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
MTH
RLAY
Price
$71.68
$19.44
Analyst Decision
Buy
Strong Buy
Analyst Count
8
10
Target Price
$77.63
$19.50
AVG Volume (30 Days)
752.3K
2.0M
Earning Date
04-22-2026
05-05-2026
Dividend Yield
2.87%
N/A
EPS Growth
N/A
31.78
EPS
2.18
N/A
Revenue
N/A
$15,355,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.81
$324.03
P/E Ratio
$32.59
N/A
Revenue Growth
N/A
53.44
52 Week Low
$58.03
$3.44
52 Week High
$85.38
$21.27

Technical Indicators

Market Signals
Indicator
MTH
RLAY
Relative Strength Index (RSI) 47.32 49.08
Support Level $68.50 $18.02
Resistance Level $78.72 $20.59
Average True Range (ATR) 2.05 0.90
MACD -0.07 -0.08
Stochastic Oscillator 28.65 26.78

Price Performance

Historical Comparison
MTH
RLAY

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising twelve states: Arizona, California, Colorado, Utah, Tennessee, Texas, Alabama, Florida, Georgia, Mississippi, North Carolina, and South Carolina. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the Homebuilding segment.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: